Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. NeuroPace Inc shares valued at $2,665,333 were sold by ORBIMED ADVISORS LLC on May 14 ’25. At $15.85 per share, ORBIMED ADVISORS LLC sold 168,136 shares. The insider’s holdings dropped to 3,238,199 shares worth approximately $34.32 million following the completion of this transaction.
Also, Morrell Martha sold 78,334 shares, netting a total of over 1,074,844 in proceeds. Following the sale of shares at $13.72 each, the insider now holds 81,993 shares.
Before that, KCK LTD. had sold 5,270,845 shares from its account. In a trade valued at $49,545,943, the 10% Owner traded NeuroPace Inc shares for $9.40 each. Upon closing the transaction, the insider’s holdings decreased to 5,270,845 shares, worth approximately $0.0.
As published in their initiating research note from H.C. Wainwright on May 28, 2025, NeuroPace Inc [NPCE] has been a Buy and the price target has been revised to $18. Analysts at UBS started covering the stock with ‘”a Buy”‘ outlook in a report released in late January. As of March 14, 2024, Wells Fargo has increased its “an Equal weight” rating to a “an Overweight” for NPCE. Earlier on January 30, 2024, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for NPCE stock.
Analyzing NPCE Stock Performance
On last trading session,, NeuroPace Inc [NASDAQ: NPCE] plunged -1.67% to $10.60. The stock’s lowest price that day was $10.451, but it reached a high of $10.9175 in the same session. During the last five days, there has been a drop of approximately -10.40%. Over the course of the year, NeuroPace Inc shares have dropped approximately -5.27%. Shares of the company reached a 52-week high of $18.98 on 05/21/25 and a 52-week low of $9.56 on 03/11/25.
Support And Resistance Levels for NeuroPace Inc (NPCE)
According to the 24-hour chart, there is a support level at 10.39, which, if violated, would cause prices to drop to 10.19. In the upper region, resistance lies at 10.86. The next price resistance is at 11.12. RSI (Relative Strength Index) is 32.47 on the 14-day chart, showing neutral technical sentiment.
Is NeuroPace Inc subject to short interest?
Stocks of NeuroPace Inc saw a sharp steep in short interest on 2025-05-30 dropping by 37895.0 shares to 0.36 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 0.39 million shares. A decline of -10.65% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.79 of the overall float, the days-to-cover ratio (short ratio) decline to 0.79.
Which companies own the most shares of NeuroPace Inc (NPCE)?
In terms of NeuroPace Inc share price expectations, FactSet research, analysts set an average price target of 13 in the next 12 months, up nearly 20.59% from the previous closing price of $10.78. Analysts anticipate NeuroPace Inc stock to reach 20 by 2025, with the lowest price target being 5.5. In spite of this, 5 analysts ranked NeuroPace Inc stock as Buy at the end of 2025. On November 10, 2023, Cantor Fitzgerald assigned a price target of “an Overweight” to the stock and initiated coverage with a $11.
